Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.
about
Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumabModulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cellsControversies in the management of primary sclerosing cholangitisIntegrin-based therapeutics: biological basis, clinical use and new drugsLiver natural killer cells: subsets and roles in liver immunityRecurrence of autoimmune liver diseases after liver transplantationAutoantibodies and an immune-based rat model of inflammatory bowel diseaseHepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalkNew horizons for studying human hepatotropic infectionsClinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current PerspectivesMAIT cells: new guardians of the liverAnalysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared lociInflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.Role of CCL25/CCR9 in immune homeostasis and disease.Glutamine supplementation attenuates expressions of adhesion molecules and chemokine receptors on T cells in a murine model of acute colitis.The fat-1 transgene in mice increases antioxidant potential, reduces pro-inflammatory cytokine levels, and enhances PPAR-gamma and SIRT-1 expression on a calorie restricted diet.Ginsan enhances humoral antibody response to orally delivered antigen.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Mechanisms of immune-mediated liver injury.The role of chemokines in the recruitment of lymphocytes to the liver.Soluble gp130 promotes intestinal epithelial hyperplasia during reovirus infection.Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host diseaseThe CC' and DE loops in Ig domains 1 and 2 of MAdCAM-1 play different roles in MAdCAM-1 binding to low- and high-affinity integrin alpha4beta7Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature reviewInfection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome.The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.Smell and taste in inflammatory bowel diseaseAdvances and controversies in the pathogenesis and management of primary sclerosing cholangitis.Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cells.Skin manifestations of inflammatory bowel disease.Dysregulated intrahepatic CD4(+) T-cell activation drives liver inflammation in ileitis-prone SAMP1/YitFc miceGut inflammation and microbiome in spondyloarthritis.Epithelial Control of Gut-Associated Lymphoid Tissue Formation through p38α-Dependent Restraint of NF-κB Signaling.Matricellular Protein Periostin Mediates Intestinal Inflammation through the Activation of Nuclear Factor κB Signaling.GIT2 deficiency attenuates concanavalin A-induced hepatitis in miceDextran sulfate sodium-induced acute colitis impairs dermal lymphatic function in mice.Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis.Lymphocyte homing and its role in the pathogenesis of IBD.
P2860
Q26750456-B809B544-09C5-4FC1-92D9-6955BF46E8F6Q26753022-0C467641-0A79-4D52-91E9-950FDC5DC95FQ26765804-5E7A381E-AC23-499E-8CDB-CB0C2B8658D2Q26773026-EC83F060-DC05-4B8A-9788-F5483CCA4A7BQ26774237-61545765-B755-40DE-B992-00BC99554E6EQ26774539-81F3D94D-C0FB-4A71-9BD3-96C9265F2E35Q26822756-31B1CF35-FCA3-4369-9F13-F99E87F6F6BBQ26829300-8A39D3A0-3D72-4E32-AA02-A7A1C4CB23F5Q27490975-9C726978-B13F-40EF-A031-65DA2195756DQ28069832-1B641676-965F-4158-B7A7-BA65CB7D4E89Q28073095-4A96442F-3A3F-4587-B2E1-23D7927BC1F5Q28393236-0FA5F07C-0B05-4A6E-9B0C-26204E1E0A8EQ30234950-4AADC531-1317-410B-98D2-A7B381E78EA7Q33579416-E5449532-99B0-4253-B60C-7C7D46577F34Q33661327-74ABFB7E-70E5-4369-BD01-A42D4E63A737Q33717017-51C389A5-015E-4F95-9860-87EF290F8CC5Q33722014-11458536-5AF6-4F59-9535-8CA4127B7B0AQ33755829-1DCF34C1-5F62-40EA-A604-0B567783F900Q33856306-DC4F7233-79B6-4BB7-B82A-8B5409938107Q33906565-20F131FB-15AA-4ABF-82E6-FBEC1CF97FB9Q33907743-5C8F4C8D-285C-4E14-8C0B-740A783115CBQ33977201-9263C60D-6118-4445-A0BC-9658A90F9292Q34178879-06D1B304-14A3-4B3D-8CAF-A75757300E3BQ34752066-AFC8129F-0841-472C-99F7-94FC6E71471CQ34814602-73E47416-627F-438E-ABE7-825F37903F89Q34909875-3319532A-96E6-4589-8A56-F86CD5E07EDDQ34994967-0AB5994D-9065-400C-9AC9-58D93781DF29Q35004760-FF71A535-E5CC-4740-ADE4-6BAE1F8782ACQ35162765-755CBBEE-7C97-4CB6-8A50-66B87F1D16F7Q35411076-37DB148D-9B0A-438F-A84A-78D2CE1711BFQ35740427-096D9AB7-631D-4037-BF2F-8F133A9A7785Q35880725-715CD34C-A182-44C5-9722-5218DCFB5D36Q35882284-C6F29734-B5FC-40EC-9AC5-39BDE9F2EC41Q35899739-6848671E-F201-4914-9727-580C2608CD30Q35927164-338E0F9A-EA01-41A6-B73F-A12CF487CFC2Q36017085-DD810302-85CD-4F47-9A5C-BA8BC41226F2Q36350214-B7728C3E-AD69-4192-B294-CE7BA18FEC6EQ36715515-E7B0A612-BF3A-4CAE-ADE4-8B9CFACDBD0FQ37087991-81FF36A5-FF35-433A-BC73-533BAA7A78BEQ37130397-4AFF6FB3-6A42-4A70-A66D-DEC789D4EAC0
P2860
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Aberrant homing of mucosal T c ...... of inflammatory bowel disease.
@ast
Aberrant homing of mucosal T c ...... of inflammatory bowel disease.
@en
type
label
Aberrant homing of mucosal T c ...... of inflammatory bowel disease.
@ast
Aberrant homing of mucosal T c ...... of inflammatory bowel disease.
@en
prefLabel
Aberrant homing of mucosal T c ...... of inflammatory bowel disease.
@ast
Aberrant homing of mucosal T c ...... of inflammatory bowel disease.
@en
P2860
P356
P1476
Aberrant homing of mucosal T c ...... of inflammatory bowel disease.
@en
P2093
Bertus Eksteen
P2860
P304
P356
10.1038/NRI1784
P50
P577
2006-03-01T00:00:00Z